Drug Type Chemical drugs |
Synonyms- |
Target |
Action activators |
Mechanism NAMPT activators(Nicotinamide phosphoribosyltransferase activators) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H18Br2N2O |
InChIKeyFZHHRERIIVOATI-UHFFFAOYSA-N |
CAS Registry301353-96-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis | Preclinical | United States | 11 Sep 2014 | |
Depressive Disorder | Preclinical | United States | 11 Sep 2014 | |
Parkinson Disease | Preclinical | United States | 11 Sep 2014 |